tryptophan has been researched along with Multiple Sclerosis, Relapsing-Remitting in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cseh, EK; Janáky, T; Kecskeméti, G; Kormány, R; Rajda, C; Szabó, E; Szabó, Z; Tömösi, F; Vécsei, L | 1 |
| Bansi, J; Bloch, W; Dalgas, U; Joisten, N; Kesselring, J; Koliamitra, C; Kool, J; Langdon, D; Schenk, A; Watson, M; Zimmer, P | 1 |
| Åkerfeldt, T; Burman, J; Herman, S; Kultima, K; Spjuth, O | 1 |
| Bansi, J; Bloch, W; Caminada, D; Dalgas, U; Gonzenbach, R; Joisten, N; Kool, J; Langdon, D; Oberste, M; Purde, MT; Rademacher, A; Schenk, A; Zimmer, P | 1 |
| Eberl, A; Ehrlich, S; Faiss, J; Fassbender, C; Galle, J; Günther, A; Harms, L; Hoffmann, F; Klingel, R; Köhler, W; Kraft, A; Riedlinger, A; Schimrigk, S | 1 |
| Amirkhani, A; Arvidsson, B; Bencsik, K; Bergquist, J; Boda, K; Markides, KE; Rajda, C; Seres, E; Vécsei, L | 1 |
| Frankish, H | 1 |
3 trial(s) available for tryptophan and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Tryptophan | 2018 |
Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
Topics: Activities of Daily Living; Adult; Biomarkers; Cognition; Cytokines; Exercise Therapy; Exercise Tolerance; Fatigue; High-Intensity Interval Training; Humans; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Quality of Life; Single-Blind Method; T-Lymphocytes, Regulatory; Th17 Cells; Time Factors; Treatment Outcome; Tryptophan | 2019 |
Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients.
Topics: Adjuvants, Immunologic; Adult; Chromatography; Female; Humans; Interferon-beta; Kynurenic Acid; Kynurenine; Male; Mass Spectrometry; Multiple Sclerosis, Relapsing-Remitting; Time Factors; Tryptophan | 2005 |
4 other study(ies) available for tryptophan and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis.
Topics: Adult; Biomarkers; Calibration; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Kynurenic Acid; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Picolinic Acids; Quinolinic Acid; Reference Standards; Tandem Mass Spectrometry; Tryptophan; Young Adult | 2020 |
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis.
Topics: Adult; Case-Control Studies; Female; Humans; Kynurenine; Male; Metabolome; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phenylalanine; Pyrimidines; Serotonin; Tryptophan | 2019 |
Escalation Therapy of Steroid Refractory Multiple Sclerosis Relapse with Tryptophan Immunoadsorption - Observational Multicenter Study with 147 Patients.
Topics: Adult; Drug Resistance; Female; Humans; Immunosorbent Techniques; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; Steroids; Tryptophan; Young Adult | 2016 |
Tryptophan metabolite improves symptoms in MS model.
Topics: Animals; Disease Models, Animal; Kynurenine; Mice; Multiple Sclerosis, Relapsing-Remitting; Neuritis, Autoimmune, Experimental; Tryptophan | 2006 |